Breaking

Russian military turns to motorbikes to evade Ukrainian drones on frontlines
Israeli airstrike rocks southern Beirut after military issues evacuation warning
Canadian Filipinos mourn after car ramming attack on their community. Here’s what we know
Trump’s plan to give Ukrainian land to Russia ‘a capitulation,’ Germany warns, as Putin thanks North Korea for troops
China rejects Trump’s claim that Xi has called him by phone
China and Philippines unfurl competing flags on disputed South China Sea sandbars, reviving tensions
Yemen’s Houthis claim dozens killed in alleged US airstrike on prison holding African migrants
Defunding DEI: Here’s how the Trump administration has undone Biden’s very prized programs

Business
Politics
World
Investing
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

RHI: Acqn of royalty over Sandstone Gold Project tenements

First patient dosed in Phase IIb imaging for Brain Mets

Binding Commitments Received for A$1.0 Million under Convertible Note Placement

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,233)
- Investing (2,897)
- Politics (3,841)
- World (3,765)

Disclaimer: WhalesInvesting.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 WhalesInvesting.com | All Rights Reserved

Top

Business
Politics
World
Investing

Type above and press Enter to search. Press Esc to cancel.